Literature DB >> 30562407

Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research.

D Mezzano1, T Quiroga2.   

Abstract

The best-known inherited mild bleeding disorders (MBDs), i.e. type 1 von Willebrand disease (VWD), platelet function disorders (PFDs), and mild to moderate clotting factor deficiencies, are characterized clinically by mucocutaneous bleeding, and, although they are highly prevalent, still pose difficult diagnostic problems. These include establishing the pathological nature of bleeding, and the uncertainties surrounding the clinical relevance of laboratory results. Furthermore, the high frequency of bleeding symptoms in the normal population and the subjective appraisal of symptoms by patients or parents makes elucidating the pathological nature of bleeding difficult. Standardized bleeding assessment tools and semiquantitative bleeding scores (BSs) help to discriminate normal from abnormal bleeding. However, as most MBDs have similar bleeding patterns, for example, bleeding sites, frequency, and severity, BSs are of little help for diagnosing specific diseases. Global tests of primary hemostasis (bleeding time; PFA-100/200) lack sensitivity and, like BSs, are not disease-specific. Problems with the diagnosis of type 1 VWD and PFD include assay standardization, uncertain definition of von Willebrand factor cut-off levels, and the lack of universal diagnostic criteria for PFD. Regarding clotting factor deficiencies, the bleeding thresholds of some coagulation factors, such as factor VII and FXI, are highly variable, and may lead to misinterpretation of the clinical relevance of mild to moderate deficiencies. Remarkably, a large proportion of MBDs remain undiagnosed even after comprehensive and repeated laboratory testing. These are tentatively considered to represent bleeding of undefined cause, with clinical features indistinguishable from those of classical MBD; the pathogenesis of this is probably multifactorial, and unveiling these mechanisms should constitute a fertile source of translational research.
© 2018 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  blood coagulation factor deficiencies; blood platelet disorders; clinical laboratory techniques; inherited coagulation disorders; von Willebrand disease, type 1

Mesh:

Year:  2019        PMID: 30562407     DOI: 10.1111/jth.14363

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  9 in total

1.  Cryptogenic oozers and bruisers.

Authors:  Kristi J Smock; Karen A Moser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency.

Authors:  Dino Mehic; Alexander Tolios; Stefanie Hofer; Cihan Ay; Helmuth Haslacher; Judit Rejtö; Willem H Ouwehand; Kate Downes; Matthias Haimel; Ingrid Pabinger; Johanna Gebhart
Journal:  Blood Adv       Date:  2021-01-26

3.  Thrombomodulin in patients with mild to moderate bleeding tendency.

Authors:  Dino Mehic; Alexander Tolios; Stefanie Hofer; Cihan Ay; Helmuth Haslacher; Kate Downes; Matthias Haimel; Ingrid Pabinger; Johanna Gebhart
Journal:  Haemophilia       Date:  2021-10-10       Impact factor: 4.263

4.  Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause.

Authors:  Stefanie Hofer; Cihan Ay; Judit Rejtö; Alisa S Wolberg; Helmuth Haslacher; Silvia Koder; Ingrid Pabinger; Johanna Gebhart
Journal:  J Thromb Haemost       Date:  2019-07-15       Impact factor: 5.824

5.  Platelet Aggregation Assays Do Not Reliably Diagnose Platelet Delta Granule Storage Pool Deficiency.

Authors:  William T Gunning; Lorene Yoxtheimer; Mary R Smith
Journal:  J Hematol       Date:  2021-07-28

6.  Reevaluation of von Willebrand disease diagnosis in a Croatian paediatric cohort combining bleeding scores, phenotypic laboratory assays and next generation sequencing: a pilot study.

Authors:  Ivana Lapić; Margareta Radić Antolic; Sara Dejanović Bekić; Désirée Coen-Herak; Ernest Bilić; Dunja Rogić; Renata Zadro
Journal:  Biochem Med (Zagreb)       Date:  2022-02-15       Impact factor: 2.313

7.  Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease.

Authors:  Ivana Lapić; Margareta Radić Antolic; Ana Boban; Desiree Coen Herak; Dunja Rogić; Renata Zadro
Journal:  Croat Med J       Date:  2022-04-30       Impact factor: 2.415

8.  Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP.

Authors:  Amandine Segot; Marcel Adler; Alessandro Aliotta; Elena Matthey-Guirao; Michael Nagler; Debora Bertaggia Calderara; Francesco Grandoni; Francisco J Gomez; Lorenzo Alberio
Journal:  J Thromb Haemost       Date:  2022-03-13       Impact factor: 16.036

9.  Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause.

Authors:  Dino Mehic; Stefanie Hofer; Christof Jungbauer; Alexandra Kaider; Helmuth Haslacher; Ernst Eigenbauer; Judit Rejtő; Dieter Schwartz; Bernd Jilma; Cihan Ay; Ingrid Pabinger; Johanna Gebhart
Journal:  Blood Adv       Date:  2020-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.